InvestorsHub Logo
Followers 0
Posts 20
Boards Moderated 0
Alias Born 10/23/2018

Re: Biobillionair post# 151545

Tuesday, 10/23/2018 6:19:57 AM

Tuesday, October 23, 2018 6:19:57 AM

Post# of 426319
BB,
I’m a first time poster, but I’ve been reading this board for years so I’d first like to thank you for all the information you’ve shared with other investors. These are great days and I attribute the information/analyses that you and the other regular posters have shared as one of the main reasons I had the confidence to hold my position through the announcement of the final analysis. Thank you.

With regards to the Boston conference, I have a different view. Mainly when presenting major study finding I think you want to first present a complete picture of the prospective study results. Presenting a slice of the data first can bias the overall picture of the study, which wouldn’t be fair to the patients/investigators who contrivbuted to the study. Also a company sponsored symposia is not the right scientific venue to release R-IT data. And finally the company has shown evidence that they preannounce their data presentations via press release. I suspect they will use the Boston meeting as a curtain raiser by discussing the design of the study and reiterating the info in the press release in order to draw more eyes towards AHA.
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent AMRN News